Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05129124 · ClinicalTrials.gov registry record · NA
Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
A NA study of Astigmatism, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05129124 is a NA study of Astigmatism that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 30 participants, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05129124, a NA study of Astigmatism, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to evaluate the fit characteristics (primary gaze orientation, rotational recovery, and movement) of kalifilcon A daily disposable toric lenses as compared to commercially available Ultra for Astigmatism lenses.
Conditions Studied
Interventions
- DEVICE kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
- DEVICE Commercially available Ultra for Astigmatism Contact Lenses
Study Locations (1)
New York
- Bausch and Lomb Site 01 - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2022-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05129124
The ClinicalTrials.gov registry entry for NCT05129124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (71% lower). The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Astigmatism appearing as the primary indexed condition, and to 2 interventions - of which kalifilcon A Daily Disposable Toric LD213001 Contact Lenses is the first listed.
NCT05129124 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05129124 about?
NCT05129124 is a clinical study titled "Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses". The objective is to evaluate the fit characteristics (primary gaze orientation, rotational recovery, and movement) of kalifilcon A daily disposable toric lenses as compared to commercially available Ultra for Astigmatism lenses.
What is the current status of trial NCT05129124?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-11-30. Estimated completion is 2022-01-13.
What conditions does trial NCT05129124 study?
This clinical trial studies the following conditions: Astigmatism.
What interventions are being tested in trial NCT05129124?
The interventions under investigation include: kalifilcon A Daily Disposable Toric LD213001 Contact Lenses (DEVICE), Commercially available Ultra for Astigmatism Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT05129124?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05129124 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astigmatism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
RECRUITING · NA
-
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
RECRUITING · NA
-
Contoura With Phorcides Compared to Wavefront Optimized LASIK
RECRUITING · NA
-
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
ACTIVE NOT RECRUITING · NA
-
LASIK iDesign vs SMILE
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.